
Ozempic Before Surgery: When to Pause and When to Restart
Most people can keep taking Ozempic before surgery, but your anesthesia team decides. The label warning, 2023-2025 guidance, liquid diets and restarting.
Written by Dr. Sheri Tomas. Updated November 15, 2026.
Most people do not need to stop Ozempic before surgery anymore, but the decision belongs to your surgical and anesthesia team, not to you alone. In 2023 the American Society of Anesthesiologists (ASA) suggested holding weekly GLP-1 drugs such as Ozempic for a week before a procedure. In October 2024, newer guidance from several medical societies, which the ASA affirmed, said most patients may keep taking these drugs, with a liquid diet for at least 24 hours beforehand for people at higher risk. A 2025 consensus went further and recommended 24 hours without solid food for everyone on these drugs. The concern is aspiration: Ozempic slows how fast the stomach empties, and food left in the stomach during anesthesia can be breathed into the lungs. This guide explains what the label says, how the advice changed, who counts as higher risk, what applies to colonoscopy and tablets, and what is known about restarting.
Ozempic Before Surgery: The Short Answer
- 1Tell your surgeon and anesthesiologist you take Ozempic as soon as a procedure is planned; the label asks patients to do this.
- 2As of November 2026, multi-society guidance says most patients may continue Ozempic before elective surgery and endoscopy.
- 3People at higher risk, such as those still increasing their dose or with stomach symptoms, may be asked to follow a liquid diet for at least 24 hours.
- 4If your team decides to hold the drug, older ASA advice of one week for weekly injections is the usual fallback, but the ideal length is unknown.
- 5Do not stop on your own: if you use Ozempic for diabetes, stopping can raise your blood sugar.
- 6No label instruction covers restarting after surgery; your team will tell you when.
Do You Need to Stop Ozempic Before Surgery?
Usually not, according to the most recent guidance, but your team decides. The October 2024 multi-society guidance, written by gastroenterology, obesity surgery, perioperative care and endoscopic surgery societies, states that most patients may continue to safely take GLP-1 receptor agonists before elective surgery and endoscopy. A GLP-1 receptor agonist is a drug that copies a gut hormone called GLP-1; Ozempic (semaglutide) is one of them, as explained in how Ozempic works. The same guidance notes that holding these drugs only because a patient has obesity could amount to weight bias.
That is not a universal rule. The surgical and anesthesia team looks at your dose, how long you have taken it, your symptoms and the type of procedure, and may still ask you to change your diet, change the timing of a dose, or hold the drug. Follow the instructions you are given for your procedure, even if they differ from what you read online, including here.
Why Does Ozempic Matter to an Anesthesiologist?
Ozempic slows gastric emptying, which means food stays in the stomach longer. That is part of how it reduces appetite. Under general anesthesia or deep sedation, the reflexes that normally protect your airway are switched off. If the stomach still contains food or liquid, some of it can come back up and be breathed into the lungs. Doctors call this pulmonary aspiration, and it can cause a serious lung infection.
Standard fasting rules exist to make sure the stomach is empty. The worry with GLP-1 drugs is that the usual fasting window may not be long enough for some people. Rare cases of aspiration have been reported in people taking these drugs, including some who had followed the standard fasting instructions.
What Does the Ozempic Label Say About Surgery and Sedation?
The current Ozempic injection label, revised in May 2026, includes a warning in section 5.10 titled "Pulmonary Aspiration During General Anesthesia or Deep Sedation". It tells patients to inform their healthcare providers before any planned surgery or procedure. The FDA added this kind of warning to GLP-1 drug labels in late 2024.
We confirmed the heading of the Ozempic section but did not read its full text. The Wegovy label, which contains the same drug, says there are "rare postmarketing reports of pulmonary aspiration" and that the available data are "insufficient to recommend changes to preoperative fasting or temporary discontinuation". In other words, the label flags the risk but does not tell you to stop the drug or fast longer. It leaves those decisions to your clinicians. How Ozempic and Wegovy relate is covered in Ozempic vs Wegovy.
How Has the Advice Changed Since 2023?
The advice has moved from holding the drug toward continuing it with diet precautions. In June 2023 the ASA published consensus-based guidance suggesting that people on daily GLP-1 drugs consider holding them on the day of the procedure and that people on weekly drugs consider holding them for a week beforehand. It also advised delaying the procedure if a patient had significant stomach symptoms on the day.
In October 2024, four societies published joint guidance: the American Gastroenterological Association (AGA), the American Society for Metabolic and Bariatric Surgery (ASMBS), the International Society of Perioperative Care of Patients with Obesity (ISPCOP), and the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). The ASA issued an affirmation of value for it. Its authors describe it as guidance rather than an evidence-based guideline, because good trial data do not exist. In June 2025 the Society for Perioperative Assessment and Quality Improvement (SPAQI) published a consensus in the British Journal of Anaesthesia, endorsed by the American Association of Clinical Endocrinology, according to a trade summary we read.
Ozempic and surgery: how the guidance changed
June 2023
American Society of Anesthesiologists
Consider holding weekly drugs for 1 week and daily drugs on the day of the procedure
Standard ASA fasting rules; delay if severe nausea, vomiting, bloating or abdominal pain
October 2024
AGA, ASMBS, ISPCOP, SAGES (affirmed by ASA)
Most patients may continue; if held, timing unknown, ASA timings used
Liquid diet for at least 24 hours for higher-risk patients
Late 2024
FDA label update
Warning on rare aspiration; data insufficient to recommend stopping
Data insufficient to recommend changing fasting
June 2025
SPAQI consensus (endorsed by AACE)
Patients do not need to discontinue
No solid food for 24 hours; no high-sugar clear liquids for 8 hours; no liquids for 4 hours
Who Is Considered Higher Risk?
The 2024 multi-society guidance lists several situations in which food is more likely to remain in the stomach:
- 1The dose-escalation phase, when the dose is still being stepped up
- 2Higher doses
- 3Weekly products such as Ozempic injections, compared with daily products
- 4Current stomach or bowel symptoms, such as nausea, vomiting, bloating or abdominal pain
- 5Other conditions that slow stomach emptying, such as gastroparesis or Parkinson's disease
If any of these apply to you, say so at your pre-operative visit. Ongoing digestive side effects are worth mentioning even if they seem minor; common ones are described in Ozempic diarrhea.
What Is the 24-Hour Liquid Diet, and Who Needs It?
Under the 2024 multi-society guidance, higher-risk patients may be asked to follow a liquid diet for at least 24 hours before the procedure while continuing their medication. The aim is to give the stomach more time to empty. The guidance also says an ultrasound of the stomach on the day of the procedure is optional, and that the choice between rapid-sequence induction (a faster technique for securing the airway) and cancelling the procedure should be shared between the team and the patient.
The 2025 SPAQI consensus applies a stricter fasting pattern to everyone on these drugs, according to a trade summary: no solid food for 24 hours, no clear liquids with high glucose (10% or more) for 8 hours, and no liquids at all for 4 hours. Your hospital will tell you which rules it uses. If you have diabetes, ask how a liquid diet affects your other medicines and blood sugar checks.
What About Colonoscopy and Upper Endoscopy?
For endoscopy, the multi-society guidance says to prioritize going ahead with the procedure and to manage people on GLP-1 drugs like patients with gastroparesis, a condition in which the stomach empties slowly. In practice this often means extra attention to diet in the day before. Colonoscopy also involves a bowel preparation, so the gastroenterology team will give instructions that cover both the bowel prep and your Ozempic. Do not skip or move a dose unless they tell you to.
Ozempic Tablets and Rybelsus Versus Weekly Injections Before a Procedure
Oral semaglutide is sold as Rybelsus, and the same label also covers a product named Ozempic tablets, described in Ozempic tablets. The tablet label has the same aspiration warning, numbered section 5.9. Because the tablets are taken daily and the injection weekly, the older ASA approach differed: holding on the day of the procedure for daily drugs and for a week for weekly drugs.
Weekly Ozempic injection vs daily semaglutide tablets before a procedure
How often it is taken
Once a week
Once a day
Hold suggested in ASA 2023 guidance
Consider holding for 1 week
Consider holding on the day of the procedure
Aspiration warning in label
Section 5.10
Section 5.9
Missed-dose rule in label
Take as soon as possible within 5 days; after more than 5 days, skip and resume schedule
Not covered in this article; ask your pharmacist
2024 multi-society default
Most may continue
Most may continue
When Can You Restart Ozempic After Surgery?
No label instruction covers restarting after surgery, so your surgical team and prescriber decide. The SPAQI consensus says to restart once you are back on your usual diet. The only related label rule is the general missed-dose instruction: if a weekly dose is missed, give it as soon as possible within 5 days; if more than 5 days have passed, skip it and return to the regular schedule. That rule is explained in what happens if you miss an Ozempic dose. Whether it applies after your procedure is a question for your team.
If the drug was held for a longer time, your prescriber may want to review the dose before you restart, because stomach side effects can return. What happens to appetite and blood sugar during a break is covered in what happens when you stop taking Ozempic.
Can You Stop Ozempic on Your Own Before a Procedure?
It is better not to. People who take Ozempic for type 2 diabetes can see their blood sugar rise if they stop, and high blood sugar around surgery brings its own risks; see Ozempic for diabetes. The current guidance also suggests that many people do not need to stop at all. If you are unsure, call the pre-operative clinic or your surgeon's office and ask what they want you to do.
When to Talk to Your Doctor
- 1As soon as any surgery, procedure or sedation is scheduled, including dental sedation
- 2If you started Ozempic or increased your dose in the weeks before the procedure
- 3If you have nausea, vomiting, bloating or abdominal pain in the days before
- 4If you take Ozempic for diabetes and are told to hold it or follow a liquid diet
- 5If you are unsure when to restart after the procedure
What to Tell Your Surgical Team
Bring this information to your pre-operative appointment, or write it down for the anesthesiologist:
- 1That you take Ozempic, your current dose, and whether you are still increasing it
- 2The day and time of your last injection, and the day you usually inject
- 3Any stomach symptoms, even mild ones
- 4Other conditions that slow digestion, such as gastroparesis
- 5Your diabetes plan, including other glucose-lowering medicines
- 6Questions to ask: Should I keep taking it? Do I need a liquid diet, and for how long? When do I restart?
For a wider view of the drug's risks and benefits, see is Ozempic safe.
The Bottom Line
The advice on Ozempic before surgery has changed. In 2023 the ASA suggested holding weekly doses for a week; since late 2024, multi-society guidance says most people may continue, with a liquid diet for higher-risk patients, and a 2025 consensus recommends 24 hours without solid food. The Ozempic label warns about rare aspiration but does not tell you to stop. Tell your team early, follow the plan they give you, and do not stop or restart on your own.
FAQ
Many people do not need to stop. Current multi-society guidance says most patients may continue. If your team decides to hold it, the older ASA timing of one week for weekly injections is often used, but the ideal length is unknown. Your surgical and anesthesia team decides.
Often yes, but ask your gastroenterology team. Guidance for endoscopy says to prioritize doing the procedure and to manage people on GLP-1 drugs like patients with slow stomach emptying, which usually means diet changes beforehand.
The ASA's 2023 guidance suggested holding weekly drugs for a week. In 2024 the ASA affirmed newer multi-society guidance saying most patients may continue. Practice varies between hospitals, so follow your own team's instructions.
If you continue as your team advised, they plan for it, for example with a liquid diet, a stomach ultrasound or a different airway technique. If you have stomach symptoms on the day, the procedure may be delayed.
There is no label rule for restarting after surgery. The SPAQI consensus says to restart once you are back on your usual diet. Ask your surgical team and prescriber.
Possibly. The 2024 guidance suggests at least 24 hours of liquids for higher-risk patients, and the 2025 SPAQI consensus suggests no solid food for 24 hours. Your hospital will tell you which rules to follow.
Sources
- 1Novo Nordisk. OZEMPIC (semaglutide) injection prescribing information, U.S. Food and Drug Administration, 2026
- 2Novo Nordisk. WEGOVY (semaglutide) prescribing information, U.S. Food and Drug Administration, 2026
- 3Novo Nordisk. RYBELSUS and OZEMPIC tablets (semaglutide) prescribing information, U.S. Food and Drug Administration, 2026
- 4Kindel TL et al. Multi-society clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period, Surgical Endoscopy, 2025 (published online 2024)
- 5American Society of Anesthesiologists. American Society of Anesthesiologists Consensus-Based Guidance on Preoperative Management of Patients (Adults and Children) on Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, American Society of Anesthesiologists news release, June 2023
- 6American Gastroenterological Association. Most patients can continue GLP-1 anti-obesity drugs before surgery, AGA, 2024
- 7Danford M. New GLP-1 guidance urges longer fasting before anesthesia, Periop Leader, June 2025 (summary of the SPAQI consensus statement in the British Journal of Anaesthesia)
This article is general information, not medical advice. Decisions about medicines before and after surgery are made by your surgical and anesthesia team. Ozempic is made by Novo Nordisk.

Dr. Sheri Tomas
Author
Comments (0)
Be the first to comment on this article.




